tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tiago Fauth, 175 are a BUY (78.48%), 41 are a HOLD (18.39%), 7 are a SELL (3.14%).
Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 47.59% that have a potential upside of 23.9% achieved within 129 days.
Tiago Fauth’s has documented 438 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 12-Oct-2026.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Sep-2026
$13
$1.18 (9.98%)
$24
1 months 1 days ago
(24-Sep-2026)
1/3 (33.33%)
$0.35 (2.77%)
4
Buy Since 05-Jan-2021
$9
$-2.82 (-23.86%)
$8
2 months 19 days ago
(06-Aug-2026)
5/9 (55.56%)
$2.47 (37.83%)
312
Buy Since 05-May-2026
$12
$0.18 (1.52%)
$11
2 months 19 days ago
(06-Aug-2026)
3/3 (100%)
$5.47 (83.77%)
53
Hold Since 05-Nov-2024
$11
$-0.82 (-6.94%)
3 months 18 days ago
(07-Jul-2026)
2/4 (50%)
$3.31 (43.04%)
561
Buy Since 16-May-2025
$12
$0.18 (1.52%)
$10
5 months 3 days ago
(22-May-2026)
5/5 (100%)
$6.8 (130.77%)
275
Which stock is Tiago Fauth most bullish on?
Which stock is Tiago Fauth most reserved on?
What Year was the first public recommendation made by Tiago Fauth?
